| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 1999 | Direct solid-phase synthesis of octreotide conjugates: precursors for use as tumor-targeted radiopharmaceuticals | Hsieh, HP; Wu, YT; Chen, ST ; Wang, KT | Bioorganic & Medicinal Chemistry 7, 1797-1803 | | | |
| 2006 | Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies | Tsai, KC; Chen, SY; Liang, PH ; Lu, IL; Mahindroo, N; Hsieh, HP; Chao, YS; Liu, L; Liu, D; Lien, W; Lin, TH; Wu, SY | J Med Chem 49, 3485-3495 | | | |
| 2004 | Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV | Hsu, JT; Kuo, CJ; Hsieh, HP; Wang, YC; Huang, KK; Lin, CP; Huang, PF; Chen, X; Liang, PH | FEBS Lett 574, 116-120 | | | |
| 2005 | Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3′-digallate (TF3) | Chen, CN; Lin, CP; Huang, KK; Chen, WC; Hsieh, HP; Liang, PH ; Hsu, JT | Evid Based Complement Alternat Med 2(2), 209-215 | | | |
| 2013 | Peptide-mediated Liposomal Doxorubicin Enhances Drug Delivery Efficiency and Therapeutic Efficacy in Lung Cancer Animal Models | Wu, HC; Chang, DK; Li, PC; Hsieh, HP | | | | |
| 2006 | Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of SARS-CoV Main Protease | Lu, IL; Mahindroo, N; Liang, PH ; Peng, YH; Kuo, CJ; Tsai, KC; Hsieh, HP; Chao, YS; Wu, SY | J Med Chem 49, 5154-5161 | | | |
